adenosine monophosphate has been researched along with milrinone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradford, K; Deb, B; Pearl, RG | 1 |
| Miyamoto, SD; Nakano, SJ; Nelson, P; Sucharov, CC | 1 |
| Ammazzalorso, A; Amoroso, R; Cicalini, I; De Filippis, B; Del Boccio, P; Della Valle, A; Di Michele, A; Gambacorta, N; Giampietro, L; Nicolotti, O; Valentinuzzi, S | 1 |
| Campbell, K; Gist, KM; Karimpour-Fard, A; Korst, A; Miyamoto, SD; Nakano, SJ; Stauffer, BL; Sucharov, CC; Wempe, MF; Zhou, W | 1 |
4 other study(ies) available for adenosine monophosphate and milrinone
| Article | Year |
|---|---|
Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
Topics: Adenosine Monophosphate; Administration, Inhalation; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Guanosine Monophosphate; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Male; Milrinone; Muscle, Smooth, Vascular; Nitric Oxide; Phosphodiesterase Inhibitors; Prospective Studies; Rabbits; Vascular Resistance; Vasodilator Agents | 2000 |
Myocardial Response to Milrinone in Single Right Ventricle Heart Disease.
Topics: Adenosine Monophosphate; Calcium-Binding Proteins; Cardiomyopathy, Dilated; Child; Child, Preschool; Female; Heart Transplantation; Heart Ventricles; Humans; Infant; Male; Milrinone; Myocardium; Phosphodiesterase 3 Inhibitors; Phosphoric Diester Hydrolases | 2016 |
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor.
Topics: Adenosine Monophosphate; Binding Sites; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Hydrogen Bonding; Mass Spectrometry; Milrinone; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Phosphodiesterase 3 Inhibitors; Protein Binding; Structure-Activity Relationship; Tandem Mass Spectrometry | 2020 |
Circulating cyclic adenosine monophosphate concentrations in milrinone treated paediatric patients after congenital heart surgery.
Topics: Adenosine Monophosphate; Cardiac Output, Low; Cardiotonic Agents; Child; Heart Defects, Congenital; Humans; Milrinone; Prospective Studies | 2021 |